1
项与 Gemcitabine Hydrochloride/Docetaxel 相关的临床试验An Open Label, Single Arm Study, to Evaluate the Safety and Efficacy of NDV01 KIT in Patients With High Grade Non Muscle Invasive Bladder Cancer (NMIBC)
High-grade NMIBC is more aggressive cancer that has a higher risk of progression and recurrence compared to low-grade NMIBC. NDV01 is a novel controlled release intravesical formulation designed for the treatment of non-muscle invasive bladder cancer (NMIBC).
100 项与 Gemcitabine Hydrochloride/Docetaxel 相关的临床结果
100 项与 Gemcitabine Hydrochloride/Docetaxel 相关的转化医学
100 项与 Gemcitabine Hydrochloride/Docetaxel 相关的专利(医药)
100 项与 Gemcitabine Hydrochloride/Docetaxel 相关的药物交易